ArticleBioanalysis2024

Assessment of mirvetuximab soravtansine immunogenicity in patients with folate receptor alpha-positive ovarian cancer.

Fengying Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.